Liquidia Corp (LQDA) Stock Price, Quote & News

Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intr...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 919 328 4400

Fax: 919 328 4402

Website: www.liquidia.com

Address:

419 Davis Drive, Suite 100, Morrisville, United States

SteelerJon Jul. 4 at 4:31 PM

$LQDA 😎🇺🇸🏦

0 · Reply

SteelerJon Jul. 4 at 11:45 AM

$LQDA 😎🏦🏦

0 · Reply

KeelinTime Jul. 3 at 1:46 PM

$LQDA

0 · Reply

stevemano Jul. 3 at 10:22 AM

$LQDA crash coming on overvalued stocks. https://youtu.be/3jqgOIKh1p0?is=x5nOEYsnMaa6QlDB

0 · Reply

MorganHoratio Jul. 2 at 11:21 PM

One of the strongest sectors outside of AI right now is Biotech. Rare Diseases $LQDA Liquidia $MBX MBX Biosciences $EWTX Edgewise Therapeutics $TVTX Travere Therapeutics $TRVI Trevi Therapeutics Money is rotating into the massive breakout trend: Rare Disease Biotech! The momentum here is wild: TVTX surged nearly 2.8x over the past year on key FDA milestones, while EWTX and TRVI both just clocked fresh all-time highs fueled by stellar data. Together with LQDA and MBX, rare disease plays offer high pricing power and exclusive markets, making them the ultimate safe haven with explosive high-beta potential. Can Rare Diseases outpace AI in H2? Which ticker is your top play: LQDA, MBX, EWTX, TVTX, or TRVI? Drop your picks below! 👇

4 · Reply

KeelinTime Jul. 2 at 1:01 PM

$LQDA

0 · Reply

BullRun4 Jul. 1 at 11:38 PM

$LQDA 💰💰👏🏻👏🏻⤵️⤵️⤵️

0 · Reply

JustAnotherAffizle Jul. 1 at 11:23 PM

$MNKD Gaslighting Nate thinks Mannkind's chart is "tasty." I am not quite sure I'd call that chart he pasted is as "tasty" as $LQDA's chart. But, when Nate isn't on here gaslighting us and moving the goal posts in regard to his take on Mannkind, I am sure he is busy working on his other hobby.

1 · Reply

JustAnotherAffizle Jul. 1 at 10:00 PM

$MNKD is up 7% in the past year (not YTD). $LQDA is up 505%. Do you not think that the narcissist stock picker would have LOVED to have had swapped LQDA with MNKD? #narcissiststockpicker #knowyournarcissist

0 · Reply

KeelinTime Jul. 1 at 7:47 PM

$LQDA

0 · Reply

Liquidia downgraded to Neutral from Buy at BofA

2026-06-22T11:32:52.000Z - 12 days ago

Liquidia price target raised to $109 from $59 at BTIG

Jun 16, 2026, 4:30 PM EDT - 18 days ago

Liquidia Transcript: AGM 2026

Jun 11, 2026, 8:30 AM EDT - 23 days ago

Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions

2026-06-08T13:08:28.000Z - 26 days ago

Liquidia announces inclusion in S&P SmallCap 600 Index

Jun 8, 2026, 8:30 AM EDT - 26 days ago

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

2026-06-05T10:55:08.000Z - 4 weeks ago

Liquidia price target raised to $75 from $67 at H.C. Wainwright

2026-06-04T19:30:40.000Z - 4 weeks ago

Raymond James sees positive readthrough for Liquidia from Hikma v. Amarin

2026-06-04T16:09:07.000Z - 4 weeks ago

Liquidia rises 17.6%

Jun 3, 2026, 12:45 PM EDT - 4 weeks ago

Liquidia Transcript: Jefferies Global Healthcare Conference 2026

May 27, 2026, 8:30 AM EDT - 5 weeks ago

Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference

May 19, 2026, 9:30 AM EDT - 6 weeks ago

Liquidia Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference

May 13, 2026, 11:40 AM EDT - 7 weeks ago

Liquidia Transcript: Bank of America Global Healthcare Conference 2026

2026-05-12T18:47:33.000Z - 7 weeks ago

Liquidia price target raised to $67 from $55 at H.C. Wainwright

2026-05-12T11:38:21.000Z - 7 weeks ago

Liquidia price target raised to $62 from $51 at Wells Fargo

2026-05-11T21:57:52.000Z - 7 weeks ago

Liquidia price target raised to $60 from $57 at Jefferies

May 11, 2026, 8:30 AM EDT - 7 weeks ago

Liquidia Earnings Call Transcript: Q1 2026

May 11, 2026, 8:30 AM EDT - 7 weeks ago

Liquidia Earnings release: Q1 2026

May 11, 2026, 8:30 AM EDT - 7 weeks ago

Liquidia Quarterly report: Q1 2026

May 11, 2026, 8:30 AM EDT - 7 weeks ago

Liquidia Slides: Q1 2026

2026-05-11T11:28:55.000Z - 7 weeks ago

Liquidia reports Q1 EPS 52c, consensus 41c

May 11, 2026, 6:30 AM EDT - 7 weeks ago

Liquidia Corporation Reports First Quarter 2026 Financial Results

May 6, 2026, 8:30 AM EDT - 2 months ago

Liquidia Corporation to Participate in Upcoming Investor Conferences

May 4, 2026, 8:30 AM EDT - 2 months ago

Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026

Apr 24, 2026, 8:00 AM EDT - 2 months ago

Liquidia Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 2 months ago

Liquidia Proxy statement: Proxy filing

Apr 15, 2026, 12:45 PM EDT - 2 months ago

Liquidia Transcript: 25th Annual Needham Virtual Healthcare Conference

2026-03-23T10:32:21.000Z - 3 months ago

Liquidia price target raised to $51 from $44 at Wells Fargo

INSM

2026-03-16T14:55:09.000Z - 3 months ago

Liquidia Technologies put volume heavy and directionally bearish

2026-03-12T11:52:04.000Z - 4 months ago

Liquidia price target raised to $19 from $16 at Oppenheimer

2026-03-06T15:06:42.000Z - 4 months ago

Liquidia rises 7.7%

2026-03-06T11:16:01.000Z - 4 months ago

Liquidia price target raised to $55 from $50 at H.C. Wainwright

2026-03-05T21:46:18.000Z - 4 months ago

Liquidia files automatic mixed securities shelf

Mar 5, 2026, 8:30 AM EST - 4 months ago

Liquidia Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 4 months ago

Liquidia Annual report: Q4 2025

Mar 5, 2026, 8:30 AM EST - 4 months ago

Liquidia Earnings release: Q4 2025

Mar 5, 2026, 8:30 AM EST - 4 months ago

Liquidia Slides: Q4 2025

Mar 5, 2026, 6:30 AM EST - 4 months ago

Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Feb 26, 2026, 7:00 AM EST - 4 months ago

Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026

Jan 14, 2026, 8:15 PM EST - 6 months ago

Liquidia Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 8:15 PM EST - 6 months ago

Liquidia Slides: 44th Annual J.P. Morgan Healthcare Conference

Nov 18, 2025, 8:00 AM EST - 8 months ago

Liquidia Transcript: Jefferies London Healthcare Conference 2025

Nov 10, 2025, 4:15 PM EST - 8 months ago

Liquidia Transcript: UBS Global Healthcare Conference 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

Liquidia Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

Liquidia Quarterly report: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

Liquidia Earnings release: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

Liquidia Slides: Q3 2025

Nov 3, 2025, 8:00 AM EST - 8 months ago

Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences

Oct 28, 2025, 3:00 PM EDT - 8 months ago

Liquidia Transcript: R&D Day 2025

Oct 28, 2025, 3:00 PM EDT - 8 months ago

Liquidia Slides: FY 2025

Oct 27, 2025, 8:30 AM EDT - 8 months ago

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

Oct 7, 2025, 6:30 AM EDT - 9 months ago

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

Sep 3, 2025, 3:45 PM EDT - 10 months ago

Liquidia Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 27, 2025, 8:30 AM EDT - 11 months ago

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Aug 12, 2025, 8:30 AM EDT - 11 months ago

Liquidia Earnings Call Transcript: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 11 months ago

Liquidia Quarterly report: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 11 months ago

Liquidia Earnings release: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 11 months ago

Liquidia Slides: Q2 2025

Aug 12, 2025, 6:30 AM EDT - 11 months ago

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Jun 23, 2025, 4:34 PM EDT - 1 year ago

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Jun 4, 2025, 11:05 AM EDT - 1 year ago

Liquidia Transcript: Jefferies Global Healthcare Conference 2025

Jun 2, 2025, 6:30 AM EDT - 1 year ago

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

May 28, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

May 27, 2025, 8:30 AM EDT - 1 year ago

Liquidia Transcript: Status Update

May 27, 2025, 8:30 AM EDT - 1 year ago

Liquidia Slides: Status Update

May 23, 2025, 2:28 PM EDT - 1 year ago

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

May 13, 2025, 4:40 PM EDT - 1 year ago

Liquidia Transcript: BofA Securities 2025 Healthcare Conference

May 12, 2025, 6:00 AM EDT - 1 year ago

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Quarterly report: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q1 2025

May 8, 2025, 6:30 AM EDT - 1 year ago

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 2, 2025, 5:28 PM EDT - 1 year ago

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

May 1, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Liquidia Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Liquidia Proxy statement: Proxy Filing

Apr 9, 2025, 8:45 AM EDT - 1 year ago

Liquidia Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 10:33 AM EDT - 1 year ago

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 28, 2025, 9:30 AM EDT - 1 year ago

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Annual report: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q4 2024

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Liquidia Registration statement: Registration Filing

Mar 19, 2025, 6:30 AM EDT - 1 year ago

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 12, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Jan 15, 2025, 12:45 PM EST - 1 year ago

Liquidia Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 12:45 PM EST - 1 year ago

Liquidia Slides: FY 2025

Nov 19, 2024, 3:00 PM EST - 1 year ago

Liquidia Transcript: Stifel 2024 Healthcare Conference

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Earnings Call Transcript: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Quarterly report: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Earnings release: Q3 2024

Nov 13, 2024, 6:30 AM EST - 1 year ago

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 7, 2024, 10:00 AM EDT - 1 year ago

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Oct 2, 2024, 6:00 AM EDT - 1 year ago

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Sep 30, 2024, 8:00 AM EDT - 1 year ago

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

Sep 19, 2024, 1:30 PM EDT - 1 year ago

Liquidia Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 16, 2024, 9:41 AM EDT - 1 year ago

Court Finds United Therapeutics' Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

SteelerJon Jul. 4 at 4:31 PM

$LQDA 😎🇺🇸🏦

0 · Reply

SteelerJon Jul. 4 at 11:45 AM

$LQDA 😎🏦🏦

0 · Reply

KeelinTime Jul. 3 at 1:46 PM

$LQDA

0 · Reply

stevemano Jul. 3 at 10:22 AM

$LQDA crash coming on overvalued stocks. https://youtu.be/3jqgOIKh1p0?is=x5nOEYsnMaa6QlDB

0 · Reply

MorganHoratio Jul. 2 at 11:21 PM

4 · Reply

KeelinTime Jul. 2 at 1:01 PM

$LQDA

0 · Reply

BullRun4 Jul. 1 at 11:38 PM

$LQDA 💰💰👏🏻👏🏻⤵️⤵️⤵️

0 · Reply

JustAnotherAffizle Jul. 1 at 11:23 PM

1 · Reply

JustAnotherAffizle Jul. 1 at 10:00 PM

0 · Reply

KeelinTime Jul. 1 at 7:47 PM

$LQDA

0 · Reply

SteelerJon Jul. 1 at 10:31 AM

$LQDA 😎🏦🏦 - https://www.investing.com/news/company-news/liquidia-technologies-stock-hits-alltime-high-at-7955-usd-93CH-4768399

0 · Reply

SteelerJon Jul. 1 at 1:20 AM

$LQDA 😎🏦

1 · Reply

WallStreetPulse Jun. 30 at 11:11 PM

$LQDA is being described in highly bullish terms following continued momentum and valuation expansion beyond the $7B level. The narrative emphasizes strong profitability and ongoing investor confidence, despite the absence of a key legal or regulatory ruling that some view as an important catalyst. The core argument presented is that based on internal due diligence, expectations lean toward a non-negative outcome, which is reinforcing conviction in the current valuation trajectory.

0 · Reply

NeverFadeTheOracle Jun. 30 at 9:56 PM

$LQDA Out 25% rip

0 · Reply

KeelinTime Jun. 30 at 9:55 PM

$LQDA

0 · Reply

JustAnotherAffizle Jun. 30 at 5:50 PM

$LQDA trading in dollars and $MNKD trading in pennies. That's the reality of one well managed company that has the attention of investors and another has-been company that has struggled to sell its flagship drug for 12+ years now.

1 · Reply

dayfornight99 Jun. 30 at 5:27 PM

$LQDA 💵😳

0 · Reply

Olivia_Strickland Jun. 30 at 5:14 PM

$LQDA breakout, up 7.0% on 630,371 volume. live tape on the breakout: https://tapeboard.com/go/st/scanner?utm_source=stocktwits&utm_medium=post&utm_campaign=olivia&utm_content=lqda-bk-up-tape&utm_term=scanner&s=LQDA

0 · Reply

MrMulally Jun. 30 at 4:37 PM

$LQDA so much for the BOFA down grading 🤣 . Another downgrade, we might hit $125

0 · Reply

Gambaa Jun. 30 at 4:19 PM

$LQDA Wow just way to strong. Know what you own.

0 · Reply

stevemano Jun. 30 at 3:05 PM

$LQDA a real pump and dumper!

0 · Reply

stevemano Jun. 30 at 3:04 PM

$LQDA strong short!

0 · Reply

Market Cap	7.02B
Revenue (ttm)	158.32M
Net Income (ttm)	-68.92M
EPS (ttm)	N/A
PE Ratio	566.57
Forward PE	26.26
Profit Margin	-43.53%
Debt to Equity Ratio	1.64

Volume	1,405,600
Avg Vol	2,015,740
Day's Range	N/A - N/A
Shares Out	88.93M
Stochastic %K	82%
Beta	0.55
Analysts	Strong Sell
Price Target	$74.25